Mevalonate kinase deficiency and Dutch type periodic fever

被引:0
|
作者
Frenkel, J
Houten, SM
Waterham, HR
Wanders, RJA
Rijkers, GT
Kimpen, JLL
Duran, R
Poll-The, BT
Kuis, W
机构
[1] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Gen Pediat, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Immunol, NL-3508 AB Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Metab Disorders, NL-3508 AB Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands
关键词
fever; IgD; hypergammaglobulinemia; mevalonate kinase; mevalonic acid; familial Mediterranean fever; periodicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dutch type periodic fever (DPF) is an autosomal recessive hereditary fever syndrome. Cases have been reported worldwide, the majority from France and The Netherlands. From infancy the patients suffer fever attacks that recur every 2-8 weeks, often precipitated by immunizations, infections or emotional stress. Fever lasts 2-7 days and can be accompanied by malaise, headache diarrhea, abdominal pain vomiting, skin rashes, arthralgia, arthritis, tender lymphadenopathy: hepatosplenomegaly and oral and genital ulcers. Labarotory evaluation during fever shows granulocytosis and elevated acute phase reactants. DPF is caused by a deficiency of the enzyme mevalonate kinase (MK). Besides DPE, the spectrum of MK deficiency includes a severe phenotype, mevalonic aciduria (MA). MA patients have less residual MK activity leading to substantially higher urinary, mevalonic acid excretion than in DPF. Mevalonic aciduria is characterized by mental retardation and dysmorphic features in addition to the clinical features of DPE At the genomic level, several mutations of varying severity have been identified The DPF phenotype is caused by one particular mild missense mutation. Most patients are compound heterozygotes for this mutation and a more severe mutation. The mechanism by which MK deficiency lends to fever is not understood. The vast majority of DPF patients have persistently, elevated serum IgD and can be classified as having hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). Conversely, most HIDS patients have MK deficiency and hence DPF, but the two disorders do not overlap entirely.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [41] Mevalonate Kinase Deficiency: Diagnostic and Management Challenges
    Puneet Kumar Choudhary
    Vivek Parihar
    Jagatshreya Satapathy
    Narendra Kumar Bagri
    Indian Journal of Pediatrics, 2021, 88 : 937 - 938
  • [42] Uveitis, glaucoma, and cataract with mevalonate kinase deficiency
    Agarwal, Nidhi
    Kothari, Mihir
    JOURNAL OF AAPOS, 2022, 26 (02): : 93 - 95
  • [43] A Clinical Criterion to Exclude the Hyperimmunoglobulin D Syndrome (Mild Mevalonate Kinase Deficiency) in Patients with Recurrent Fever
    Steichen, Olivier
    van der Hilst, Jeroen
    Simon, Anna
    Cuisset, Laurence
    Grateau, Gilles
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (08) : 1677 - 1681
  • [44] Identification of an active site alanine in mevalonate kinase through characterization of a novel mutation in mevalonate kinase deficiency
    Hinson, DD
    Chambliss, KL
    Hoffmann, GF
    Krisans, S
    Keller, RK
    Gibson, KM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) : 26756 - 26760
  • [45] Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in Hyper-IgD and periodic fever syndrome
    Houten, SM
    Frenkel, J
    Rijkers, GT
    Wanders, RJA
    Kuis, W
    Waterham, HR
    HUMAN MOLECULAR GENETICS, 2002, 11 (25) : 3115 - 3124
  • [46] Dutch type periodic fever in a Turkish infant also having MEFV mutation
    B Makay
    F Demirciooglu
    M Duman
    E Ünsal
    Pediatric Rheumatology, 6 (Suppl 1)
  • [47] Natural history of mevalonate kinase deficiency: a literature review
    Zhang, Shumin
    PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [48] Interleukin-1 antagonists in Mevalonate Kinase Deficiency
    C Galeotti
    L Rossi-Semerano
    S Guillaume
    A Duquesne
    P Pillet
    O Richer
    E Hachulla
    I Koné-Paut
    Pediatric Rheumatology, 9 (Suppl 1)
  • [49] Biochemical and genetic aspects of mevalonate kinase and its deficiency
    Houten, SM
    Wanders, RJA
    Waterham, HR
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3): : 19 - 32
  • [50] CURRENT ADVANCES IN THE UNDERSTANDING AND TREATMENT OF MEVALONATE KINASE DEFICIENCY
    Esposito, S.
    Ascolese, B.
    Senatore, L.
    Bosis, S.
    Verrecchia, E.
    Cantarini, L.
    Rigante, D.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (04) : 491 - 498